In conclusion, using an intense allergy induction protocol in pigs, we demonstrated that Lactobacillus rhamnosus HN001 supplementation reduced the severity of allergic lung outcomes and was accompanied by a tendency of increased Th1 (IFN-γ) responses balanced with increased regulatory responses (IL-10 production) to the allergen. This evidence concerns the gene IFNG and allergic disease.